UroGen Pharma Ltd. (URGN)
33.48
-0.27
(-0.80%)
USD |
NASDAQ |
Oct 29, 16:00
33.15
-0.33
(-0.99%)
After-Hours: 20:00
UroGen Pharma Market Cap : 1.636B for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 1.636B |
| October 28, 2026 | 1.649B |
| October 27, 2026 | 1.657B |
| October 26, 2026 | 1.664B |
| October 23, 2026 | 1.686B |
| October 22, 2026 | 1.718B |
| October 21, 2026 | 1.734B |
| October 20, 2026 | 1.711B |
| October 19, 2026 | 1.669B |
| October 16, 2026 | 1.689B |
| October 15, 2026 | 1.789B |
| October 14, 2026 | 1.788B |
| October 13, 2026 | 1.870B |
| October 12, 2026 | 1.871B |
| October 09, 2026 | 1.800B |
| October 08, 2026 | 1.807B |
| October 07, 2026 | 1.989B |
| October 06, 2026 | 2.025B |
| October 05, 2026 | 2.091B |
| October 02, 2026 | 2.023B |
| October 01, 2026 | 1.982B |
| September 30, 2026 | 1.986B |
| September 29, 2026 | 1.977B |
| September 28, 2026 | 1.999B |
| September 25, 2026 | 2.021B |
| Date | Value |
|---|---|
| September 24, 2026 | 2.015B |
| September 23, 2026 | 2.034B |
| September 22, 2026 | 2.090B |
| September 21, 2026 | 2.111B |
| September 18, 2026 | 2.114B |
| September 17, 2026 | 2.148B |
| September 16, 2026 | 2.125B |
| September 15, 2026 | 2.040B |
| September 14, 2026 | 2.084B |
| September 11, 2026 | 2.068B |
| September 10, 2026 | 2.064B |
| September 09, 2026 | 2.199B |
| September 08, 2026 | 2.141B |
| September 04, 2026 | 2.155B |
| September 03, 2026 | 2.193B |
| September 02, 2026 | 2.171B |
| September 01, 2026 | 2.120B |
| August 31, 2026 | 2.106B |
| August 28, 2026 | 2.132B |
| August 27, 2026 | 2.224B |
| August 26, 2026 | 2.245B |
| August 25, 2026 | 2.266B |
| August 24, 2026 | 2.256B |
| August 21, 2026 | 2.290B |
| August 20, 2026 | 2.287B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Xencor, Inc. | 2.171B |
| MeiraGTx Holdings Plc | 914.10M |
| Insmed, Inc. | 24.36B |
| Ironwood Pharmaceuticals, Inc. | 598.17M |
| Viking Therapeutics, Inc. | 3.425B |
Market Cap Related Metrics
| PS Ratio | 8.735 |
| Price | 33.48 |
| Earnings Yield | -5.96% |